Effects of simvastatin on bone regeneration in the mandibles of ovariectomized rats and on blood cholesterol levels.

The purpose of this study was to evaluate the effects of simvastatin on guided bone regeneration in the mandibles of ovariectomized rats, and to observe their blood cholesterol levels. Seventy female rats were divided into two groups: control and treated, both groups containing normal and ovariectom...

Descripción completa

Detalles Bibliográficos
Autores: Junqueira, Juliana Campos [UNESP], Mancini, Maria N G, Carvalho, Yasmin R, Anbinder, Ana Lia, Balducci, Ivan, Rocha, Rosilene F
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2002
País:Brasil
Institución:Universidade Estadual Paulista (UNESP)
Repositorio:Repositório Institucional da UNESP
Idioma:inglés
OAI Identifier:oai:repositorio.unesp.br:11449/67083
Acceso en línea:http://dx.doi.org/10.2334/josnusd.44.117
http://hdl.handle.net/11449/67083
Access Level:acceso abierto
Palabra clave:cholesterol
hydroxymethylglutaryl coenzyme A reductase inhibitor
hypocholesterolemic agent
politef
simvastatin
analysis of variance
animal
artificial membrane
blood
bone density
bone regeneration
drug effect
female
jaw disease
mandible
ovariectomy
pathology
radiodensitometry
rat
statistics
tissue regeneration
Wistar rat
Analysis of Variance
Animals
Anticholesteremic Agents
Bone Density
Bone Regeneration
Cholesterol
Densitometry, X-Ray
Female
Guided Tissue Regeneration
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Mandible
Mandibular Diseases
Membranes, Artificial
Ovariectomy
Polytetrafluoroethylene
Rats
Rats, Wistar
Simvastatin
Statistics
Descripción
Sumario:The purpose of this study was to evaluate the effects of simvastatin on guided bone regeneration in the mandibles of ovariectomized rats, and to observe their blood cholesterol levels. Seventy female rats were divided into two groups: control and treated, both groups containing normal and ovariectomized rats. A month after ovariectomy a bone defect was created in the mandible, and was covered by a polytetrafluoroethylene membrane. The treated groups received simvastatin orally for 15 or 30 days. The rats were sacrificed 15, 30 or 60 days after surgery, at which time a blood sample was extracted for blood cholesterol level analysis and the mandible was extracted for densitometric, histological and morphometric analysis. All specimens underwent analysis of variance. The ovariectomized animals had higher cholesterol levels than the treated normal animals, and no significant difference was found between the different treatment periods and the sacrifice times. The densitometric, histological and morphometric analysis showed that the treated ovariectomized animals developed more new bone than the control ovariectomized rats, but no significant difference was observed between the treatment periods. It can be concluded that the deficiency of estrogen increased the level of blood cholesterol and that the simvastatin aided new bone formation in the ovariectomized animals.